DOHA: Hamad Medical Corporation’s (HMC) Head of Research at the Department of Medicine has been selected to be part of the prestigious committee reviewing research grants applications in the United States. Dr Ramzi Mohammed (pictured), was invited by the US National Institutes of Health (NIH) to be one of the official reviewers of their grant proposals. The committee, which is the highest healthcare grants authority in that country, meets in Washington DC and oversees millions of dollars of grants for research each year.
Dr Ramzi has more than 25 years of translational research, including extensive experience in molecular biology, animal models and tissue culture. He has established a number of cancer cell lines and was among the first to establish orthotopic animal models; in which he has years of experience, studying the effects of new anticancer agents, marine products, and standard chemotherapeutic drugs.
“The National Institutes of Health is an agency of the US Department of Health and Human Services and is the primary agency of the government responsible for biomedical and health-related research,” says Dr Ramzi. “This process is very competitive and its objective is to acquire new knowledge that helps prevent, detect, diagnose and treat disease (and disabilities).”
Dr Ramzi joined HMC late last year before that was the Director of GI-Cancer Research at Wayne State University in Michigan in the US.
Dr. Ramzi is a recipient of funding by National Cancer Institute at the National Institute of Health and he is the Principle Investigator of three active grants (which are worth millions of dollars).
The Peninsula
